Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.
Global markets retreat as early AI-driven gains evaporate. Asian and European stocks decline while investors await key economic data and Federal Reserve signals.
Breaking exploration results from West Red Lake Gold Mines show exceptional high-grade gold intersections in the Lower Austin Zone, signaling strong growth potential for this promising Canadian gold project.
Discover why Canadian equities are beating U.S. markets as Trump's potential return creates investor uncertainty. Analysis of TSX vs S&P 500 performance and sector outlook.
Snap Inc. warns investors that a looming November government shutdown could severely impact the social media advertising landscape, creating uncertainty for tech companies reliant on digital marketing revenue.
Canadian media giant Corus Entertainment announces groundbreaking recapitalization strategy, converting substantial debt into shares while securing new financing to navigate evolving broadcast landscape.
Two prominent Canadian mining companies navigate challenging market conditions as Coeur Mining reports significant losses and New Gold implements strategic changes to weather the storm.
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
Ardena strengthens its leadership with strategic hires of Chief Quality Officer and Chief Information Officer to drive operational excellence and digital transformation in pharmaceutical services.
In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.
In a landmark healthcare deal, Kimberly-Clark acquires Kenvue, the consumer health giant behind Tylenol, Band-Aid and Listerine, reshaping the North American healthcare landscape.
Global markets surge as technology shares lead another week of gains, with U.S. futures pointing higher amid renewed investor confidence and economic optimism.
Nvidia's staggering Q1 earnings reveal unprecedented growth, positioning the chipmaker as the standout performer among elite tech stocks. Discover how AI demand is fueling this remarkable surge.
Facebook's parent company Meta Platforms delivered stunning Q1 earnings, crushing expectations and triggering a wave of analyst upgrades that position it as the standout performer among tech giants.
Wall Street witnesses history as Big Tech's earnings explosion fuels unprecedented market dominance. Discover which companies are driving the longest winning streak in decades.
Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.
BMO's veteran investment strategist Brian Belski reveals why he's betting big on Canadian stocks despite market skepticism. Discover his contrarian outlook for TSX performance and sector opportunities.
Lundin Gold's Q3 2025 report reveals stellar results from the Fruta del Norte mine, including record gold production, robust financials, and a 50% dividend increase, marking a period of exceptional growth and shareholder returns.
Meta Platforms Inc. makes waves in corporate finance with a stunning $10 billion bond offering, signaling aggressive growth plans despite market volatility. Discover what this means for investors and the tech landscape.
Canada's main stock index surged more than 100 points Tuesday, led by strong performances in base metals and financial sectors, while U.S. markets showed mixed results amid economic uncertainty.
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
US stocks retreated Wednesday as investors digested conflicting signals from Big Tech earnings and escalating US-China trade relations, creating market uncertainty.
Canadian Pacific Kansas City shatters expectations with $3.2B Q3 revenue as freight volumes climb. Discover how this railway giant is driving North American trade.
As tech giants Meta and Microsoft pour billions into artificial intelligence infrastructure, investors are growing restless waiting for returns. Discover how massive AI spending is reshaping the tech landscape and testing Wall Street's patience.
A new report reveals Canadian oil sands companies are gaining competitive advantages over U.S. shale producers, with lower decline rates and stronger financial performance attracting investor attention.
Australian explorer Inflection Resources reveals significant copper-gold mineralization targets spanning 30km at their Endurance Project, signaling major discovery potential in mining-rich Northern Territory.
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.
A former Melita pharmacy manager faces consequences after being convicted of multiple professional misconduct charges, including improper prescription practices and record-keeping failures.
Canadian energy company Parex Resources announces strategic proposal to acquire GeoPark while revealing substantial 11.8% ownership stake, signaling major consolidation in Latin American oil and gas markets.